Drugmakers Skeptical as Savings Estimate in Settlement Ban Doubles
The Congressional Budget Office (CBO) estimate of the potential savings from a pending Senate bill to limit reverse patent settlements is drawing fire and skepticism from drugmakers.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.